Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2004;63(Supplement 2 ):ii50-ii56; doi:10.1136/ard.2004.028258
Copyright © 2004 BMJ Publishing Group Ltd & European League Against Rheumatism.
Annals of the Rheumatic Diseases 2004;63:ii50-ii56
© 2004 by BMJ Publishing Group Ltd & European League Against Rheumatism

REPORT

Clinical aspects

New issues in tuberculosis

S H E Kaufmann

Correspondence to:
Correspondence to:
Professor S H E Kaufmann
Max Planck Institute for Infection Biology, Department of Immunology, Schumannstr, 21-22, 10117 Berlin, Germany; kaufmann{at}mpiib-berlin.mpg.de

Tuberculosis remains a major health problem worldwide. The disease is caused by Mycobacteriumtuberculosis whose preferred habitat is the host macrophage. The immune response against tuberculosis is mediated by different subsets of T cells including both conventional CD4 and CD8 T cells as well as unconventional CD1 restricted and {gamma}{delta} T cells. The CD1 restricted T cells are particularly remarkable because they recognise the glycolipids abundant in the mycobacterial cell wall. Although a vaccine, M.bovis BCG, is available which protects toddlers against miliary tuberculosis, it is ineffective in preventing pulmonary tuberculosis in adults. Therefore, a novel vaccine is urgently required. Knowledge about the functioning of different T cell populations during infection and disease provides the basis for rational vaccine design. We have constructed a recombinant BCG vaccine which, compared with wild-type BCG, induces superior protection not only against laboratory strains but also against clinical isolates of M. tuberculosis.

Abbreviations: BCG, bacille Calmette Guérin; hly, listeriolysin; MDR, multidrug resistance; MHC, major histocompatibility complex

Keywords: tuberculosis; Mycobacterium tuberculosis; vaccine design; BCG vaccine; phagosome maturation; macrophages; T cell; major histocompatibility complex


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Tsenova, L., Harbacheuski, R., Moreira, A. L., Ellison, E., Dalemans, W., Alderson, M. R., Mathema, B., Reed, S. G., Skeiky, Y. A. W., Kaplan, G. (2006). Evaluation of the Mtb72F Polyprotein Vaccine in a Rabbit Model of Tuberculous Meningitis. Infect. Immun. 74: 2392-2401 [Abstract] [Full Text]  
  • Praprotnik, S, Rozman, B, Tomsic, M, Kaufmann, S H E (2005). New issues in tuberculosis * Author's reply. Ann Rheum Dis 64: 795-795 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs